课题基金 / 基金详情

CLINICAL ONCOLOGY PROGRAM

CLINICAL ONCOLOGY PROGRAM
临床肿瘤学项目
批准号:
2088818
负责人:
Howard M Gross
金额:
$23.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-09-15 至 1995-05-31

项目摘要

项目成果

Howard M Gross的其他基金

相关文献

中文摘要
翻译
俄亥俄州代顿的五家医院合作组建了 代顿临床肿瘤学项目(DCOP)。 NCI社区临床 肿瘤学计划(CCOP)涉及代顿的所有主要机构 具有社区合作历史的特定人口区域 在医疗项目开发和癌症领域。 DCOP已经 能够在短时间内调动其资源, 机构组成部分和卫生保健专业人员, 发展一个更复杂的癌症项目。 DCOP的具体目标和 目标包括:更多地参与临床研究, 建立强有力的组织结构, 支持和管理数据管理计划的程序开发, 高水平的质量控制,将确保NCI的上级数据, 项目评估;建立医师绩效标准; 制定药房程序,确保NCI、FDA和其他机构 对研究药物的控制; 医学界在癌症控制活动中的作用,特别是医生和 护理患者管理指南。 为了实现主要目标, 增加参与临床研究,DCOP提供了 制定议定书的标准/政策 选择; NCI评估扩散假说的机制, 包括编制病人日志表,并提供额外的 通过计算机化数据系统收集数据;建立数据管理 职责;数据管理计划的设计;数据管理程序 维护、质量控制和传输到研究基地; 研究药物的使用政策。
英文摘要
Five hospitals in Dayton, Ohio have collaborated in the formation of the Dayton Clinical Oncology Program (DCOP). This NCI Community Clinical Oncology Program (CCOP) involves all major institutions within Dayton's defined population area with a history of community collaboration efforts in medical program development and in the cancer field. The DCOP has been able, in a short period of time, to mobilize the resources of its institutional components and health care professionals to initiate development of a more sophisticated cancer program. DCOP specific aims and objectives include: greater involvement in clinical research at the community level; establishment of a strong organizational structure to support and govern the program development of a data management plan with a high level of quality control that will assure the NCI of superior data for program evaluation; establishment of standards of physician performance; development of pharmacy procedures assuring the NCI, FDA and other agencies of control over investigational agents; and greater involvement of the medical community in cancer control activities, especially physician and nursing patient management guidelines. To accomplish the primary goal of increased involvement in clinical research, the DCOP has provided the following methodology: development of criteria/policies for protocol selection; mechanisms for NCI's evaluation of the diffusion hypothesis, including development of patient log forms with provision of additional data through the computerized data system; establishment of data management responsibilities; design of a data mangement plan; procedures for data maintenance, quality control and transmission to the research bases; and policies for use of investigational drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dayton Clinical Oncology Program
  • 批准号:
    9320521
  • 项目类别:
  • 资助金额:
    $93.61万
  • 财政年份:
    2014
  • 负责人:
    Howard M Gross
  • 依托单位:
Dayton Clinical Oncology Program
  • 批准号:
    9770709
  • 项目类别:
  • 资助金额:
    $93.06万
  • 财政年份:
    2014
  • 负责人:
    Howard M Gross
  • 依托单位:
Dayton Clinical Oncology Program
  • 批准号:
    8790597
  • 项目类别:
  • 资助金额:
    $100.5万
  • 财政年份:
    2014
  • 负责人:
    Howard M Gross
  • 依托单位:
Dayton Clinical Oncology Program
  • 批准号:
    10673173
  • 项目类别:
  • 资助金额:
    $89.63万
  • 财政年份:
    2014
  • 负责人:
    Howard M Gross
  • 依托单位: